HYPERFINE INC
HYPRNASDAQTrading Snapshot
- Day Range
- $0.72 – $0.78
- 52-Week Range
- $0.70 – $1.94
- Volume (shares)
- 937,531
- Avg Volume (shares)
- —
- Shares Outstanding
- 106.0M
- Next Earnings
- 2026-11-09
Fundamentals Snapshot
- Annual Revenue
- $14M
- Last Q Revenue
- $4M
- P/E Ratio
- —
- P/S Ratio
- 4.8x
- EPS (TTM)
- $-0.38
- Dividend Yield
- —
- Dilution (1yr)
- +28.8%
HYPERFINE INC
HYPR
StockOtter · stockotter.spaceAbout HYPERFINE INC
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
GUILFORD, Conn.--(BUSINESS WIRE)--CE mark and UKCA approvals support Swoop system Model 2 expansion as Hyperfine highlights portable MRI in brain health awareness efforts.
Hyperfine (NASDAQ: HYPR) revenue tops cash burn as it secures $40 million loan
What happened Hyperfine, Inc. (NASDAQ: HYPR) said preliminary third-quarter revenue rose to about $6.0 million, while preliminary net cash burn fell to about $5.6 million. The company said revenue topped preliminary net
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the
Neuralink Stock: How to Invest Before the IPO
You can't buy Neuralink stock yet, but its supply chain is already public. Here are the brain-computer interface stocks to watch before the Neuralink IPO.
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine appoints Roots Pharmaceutical as exclusive Swoop system distributor in the United Arab Emirates and Kuwait.